Nipro Trading (Shanghai) Co., Ltd.

NIPRO Corporation, established in 1954, operates across medical, pharmaceutical, and glass product sectors. For 65 years, NIPRO has been consistently dedicated to the research and innovation of cutting-edge medical products, continuously challenging the unknown realms of life sciences. Today, NIPRO stands at the forefront of global medical care, providing exceptional technology and products across various fields such as medical devices and pharmaceuticals. Numerous patented technologies applied in artificial kidneys and various disposable medical devices have endowed these products with unprecedented functions and characteristics. In 2018, NIPRO's annual sales reached $5 billion, with 29,000 employees worldwide. NIPRO has 77 subsidiaries, 4 sister companies, 20 medical factories, 11 pharmaceutical factories, and 19 glass factories distributed across Asia, Europe, the Americas, Oceania, and Africa. Nipro Trading (Shanghai) Co., Ltd. was officially established in Shanghai in 2003, primarily engaged in the sales of NIPRO's related products in the Chinese market. Currently, it has 12 offices nationwide (Harbin, Shenyang, Beijing, Xi'an, Zhengzhou, Nanjing, Changsha, Wuhan, Chengdu, Xiamen, Kunming, Guangzhou). Since 1993, it has assisted clinical dialysis treatment development in China, donating dialysis machines to 10 Chinese hospitals free of charge, which has saved many patients and enabled hospitals to conserve significant funds. The unwavering pursuit of product quality has earned NIPRO high acclaim in the global clinical medical field. In particular, in the fields of renal artificial organs and regenerative medicine, NIPRO has become a world-leading brand.